Beroni Group Overview
Company Headquarters: Sydney, Australia
Founded: 2014
Workforce: ~57
Company Working: Beroni Group is a global biopharmaceutical company that is involved in the development of innovative drugs and therapies for the treatment of various diseases such as cancer and infectious disease. The company’s diverse product portfolio includes virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting cancer and cell therapies. Beroni is majorly involved in developing and commercializing innovative immune cell therapies as well as new drugs to capture the unmet medical needs of cancer patients in China and worldwide. The company has operations in Australia, US, China, and Japan.
Strategy
Beroni Group focuses on forming alliances with various healthcare professionals around the globe to address peoples' requirements for advanced treatment. To enhance its product portfolio, the company also conducts research and development on medically supported and scientifically defined cell therapy and anticancer and infectious disease products. Moreover, the company is focused on developing the broadest range of antibody flagship brands and services, as well as on producing consumer and customer data insights. Additionally, it also focused on providing commercial excellence through its multichannel go-to-market methodology.
